The Large Molecule Drug Substance CDMO Market is witnessing remarkable growth as pharmaceutical and biotechnology companies increasingly rely on specialized contract development and manufacturing organizations (CDMOs) to produce complex biologic therapies. According to Polaris Market Research, the market was valued at USD 51.89 billion in 2024 and is projected to grow from USD 55.77 billion in...
Bangla